Advertisement

Topics

DICOPANOL | Dicopanol [Fusion Pharmaceuticals LLC] | BioPortfolio

13:39 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Do not use if safety seal is broken NDC 43093-104-01 Rx only FusePaq™   Oral Suspension Kit DICOPANOL™ (diphenhydramine hydrochloride 5 mg/mL, in oral suspension kit) Description: This kit contains active and inactive bulk materials to prepare 150 mL of a  diphenhydramine hydrochloride oral suspension containing 5 mg/mL diphenhydramine hydrochloride. This kit may only be used for the extemporaneous combining of these ingredients by an appropriate licensed medical professional in response to a physician's prescription to create a medication tailored to the specialized needs of an individual patient. Active Ingredient:

Inactive Ingredients:

Store kit at room temperature, 15-30 degrees C (59-86 degrees F) U.S. Patents Pending   FUSION PHARMACEUTICALS   786 Calle Plano  Camarillo CA 93012 CS68-A1 rev 2

Do not use if safety seal is broken

Diphenhydramine Hydrochloride Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride Rx Only CAS# 147-24-0 Net contents: 0.75 g Repackaged by: Fusion Pharmaceuticals, LLC Camarillo, CA 93012 CS65-A1 rev 1

Do not use if safety seal is broken Oral Suspension Vehicle Sugar, dye, and paraben free Ingredients: water, glycerin, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, melatonin, potassium sorbate, sodium benzoate Net Contents: 150 mL (5.1 fl oz) Manufactured for: Fusion Pharmaceuticals, LLC Camarillo, CA 93012 CS66-A1 rev 1

NDC 43093-104-01 Rx Only FusePaq tm  DICOPANOL tm (diphenhydramine hydrochloride 5 mg/mL, oral suspension- kit) FusePaq tm kits provide a convenient approach to rapidly create prescription medications, as all components are pre-measured. This kit is manufactures according to US FDA current Good Manufacturing Practice (cGMP). Description: This kit contains active and inactive bulk materials to create a diphenhydramine hydrochloride oral suspension. These instructions describe how to prepare 150 mL of oral suspension containing 5 mg/mL diphenhydramine hydrochloride. Other concentrations are possible. Exact strength of the resulting final suspension must be defined by the prescriber. Contents: - 0.75 g diphenhydramine hydrochloride, USP - 150 mL oral suspension vehicle (water, glycerin, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, melatonin, potassium sorbate, sodium benzoate) Instructions for the Pharmacist Diphenhydramine hydrochloride, 5 mg/mL oral suspension 1    Remove and Inspect the Contents of the Kit Ensure that the safety seals are present and intact on the diphenhydramine hydrochloride and oral suspension vehicle bottles. If the seals are not intact, do not use the kit. 2    Prepare for Combining Wear gloves and eye protection during combining operations. Remove the seal from the oral suspension bottle. Break the perforated seal and remove the cap from the diphenhydramine hydrochloride bottle. 3    Transfer Diphenhydramine Hydrochloride to the Suspension Bottle Uncap the suspension bottle. Pour a small amount of suspension liquid (approximately one-third to one-half the volume of the diphenhydramine hydrochloride bottle) into the diphenhydramine hydrochloride bottle. Cap the diphenhydramine hydrochloride bottle and shake well several times to dissolve the diphenhydramine hydrochloride powder. Empty the contents into the suspension bottle. Cap and combine the suspension bottle. Repeat this step 3 times. Visually ensure that all of the diphenhydramine hydrochloride has been dissolved and transferred to the suspension bottle. 4    Complete the Combining Process Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Shake well by inverting repeatedly several times. 5    Re-label the Resulting Final Suspension Label the resulting final suspension per the pharmacy's standard practice. Remove or obscure the oral suspension vehicle label, since the label is no longer accurate once the resulting final suspension is completed. Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the resulting final suspension between 15-30°C (59-86°F). The resulting final suspension is stable for at least eight weeks, based upon real-time and accelerated stability studies. Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test 61. In addition, the suspension vehicle formulation has passed the USP 51 Antimicrobial Effectiveness Test. An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension. U.S. Patents Pending Manufactured by: Fusion Pharmaceuticals, LLC 768 Calle Plano Camarillo, CA 93012 CS67-A1 rev 1

Manufacturer

Diffusion Pharmaceuticals LLC

Active Ingredients

Source

Clinical Trials [0 Results]

None

PubMed Articles [0 Results]

None

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record